PAK1 and cancer: It was suggested that this involves OIS, cell cycle arrest at the G1/S phase, and downregulation of cyclin-A, cyclin-D1, and cyclin-E (Du et al., 2016), especially in cancers arising from PAK1-expressing tissues, such as brain, pancreas, colon, or ovary (Grebenova et al., 2019).